Trials / Completed
CompletedNCT06470100
Dexamethasone vs. Dexmedetomidine for ESPB in Pain Management After Knee Arthroplasty
Dexamethasone vs. Dexmedetomidine for ESPB in Pain Management After Total Knee Arthroplasty
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 90 (actual)
- Sponsor
- Poznan University of Medical Sciences · Academic / Other
- Sex
- All
- Age
- 18 Years – 100 Years
- Healthy volunteers
- Not accepted
Summary
Effect of perineurial dexamethasone and dexmedetomidine on erector spinal plane block duration for knee arthroplasty
Detailed description
This study is proposed to explore the effect of perineurial Dexamethasone and Dexmedetomidine on erector spinal plane block duration for knee surgery. After knee surgery, patients need good analgesia. Peripheral nerve blocks have provided a safe, effective method to control early postoperative pain when symptoms are most severe. Local anaesthesia's much lower toxicity threshold makes it essential for its safety. An effective adjuvant, such as Dexamethasone or Dexmedetomidine, could allow for a higher dilution of local anaesthetics while maintaining and enhancing their analgesic effect. There is considerable research comparing intravenous and perineural dexamethasone and Dexmedetomidine use in orthopaedic surgeries. However, there is a massive lack of research regarding knee surgery and the Erector Spine Plane Block. In this study, investigators compare perineural Dexamethasone and Dexmedetomidine. The investigator aims to find a dexamethasone or dexmedetomidine that covers the need for good pain relief and fast recovery postoperatively.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | 0.9% Sodium Chloride Injection | unilateral administration of 20ml of 0,2% ropivacaine + 2ml 0.9% sodium chloride for the erector spine plane block |
| DRUG | Dexamethasone | unilateral administration of 20ml of 0,2% ropivacaine with 4mg Dexamethasone for the erector spine plane block |
| DRUG | Dexmedetomidine | unilateral administration of 20ml of 0,2% ropivacaine with 50ug Dexmedetomidine for the erector spine plane block |
Timeline
- Start date
- 2024-08-13
- Primary completion
- 2026-03-03
- Completion
- 2026-03-20
- First posted
- 2024-06-24
- Last updated
- 2026-03-30
Locations
1 site across 1 country: Poland
Source: ClinicalTrials.gov record NCT06470100. Inclusion in this directory is not an endorsement.